ALS research accelerated with new iPSC repository
The largest resource for amyotrophic lateral sclerosis (ALS) research has been made accessible to researchers worldwide.
Answer ALS (LA, USA) and Cedars-Sinai (CA, USA) have unveiled the largest repository of ALS patient-derived induced pluripotent stem cells (iPSCs) and associated biological data. This comprehensive collection includes clinical and biological data from nearly 1000 ALS patients, providing an invaluable resource for researchers worldwide studying ALS.
